Reza  Zadno net worth and biography

Reza Zadno Biography and Net Worth

Dr. Zadno has served as our President and Chief Executive Officer and a member of our board of directors since February 2020. He previously served as President and Chief Executive Officer of Avedro, Inc., a ophthalmology company, from September 2016 to November 2020, where he also served as a member of the board of directors from September 2016 to November 2020. Dr. Zadno also previously served as Innovation Advisor and Venture Partner at InterWest Partners, a venture capital firm, from January 2012 to January 2018. Dr. Zadno has also served on the boards of directors of Invuity, Inc. from January 2013 to June 2017, where he was a member of the audit committee, and Carbylan Therapeutics, Inc. from June 2013 to November 2016, where he was a member of the audit committee. In addition, Dr. Zadno has served as a public trustee on the board of the American Academy of Ophthalmology, since January 2024. Dr. Zadno received both a Ph.D. and an M.Sc. in Mechanical Properties of Materials (Metallurgy) from Ecole Nationale Superieure des Mines de Paris.

What is Reza Zadno's net worth?

The estimated net worth of Reza Zadno is at least $9.88 million as of March 18th, 2025. Dr. Zadno owns 173,070 shares of PROCEPT BioRobotics stock worth more than $9,880,566 as of April 1st. This net worth estimate does not reflect any other assets that Dr. Zadno may own. Additionally, Dr. Zadno receives a salary of $1,130,000.00 as CEO at PROCEPT BioRobotics. Learn More about Reza Zadno's net worth.

How old is Reza Zadno?

Dr. Zadno is currently 69 years old. There are 5 older executives and no younger executives at PROCEPT BioRobotics. Learn More on Reza Zadno's age.

What is Reza Zadno's salary?

As the CEO of PROCEPT BioRobotics Co., Dr. Zadno earns $1,130,000.00 per year. Learn More on Reza Zadno's salary.

How do I contact Reza Zadno?

The corporate mailing address for Dr. Zadno and other PROCEPT BioRobotics executives is 900 ISLAND DRIVE, REDWOOD CITY CA, 94065. PROCEPT BioRobotics can also be reached via phone at 650-232-7200 and via email at ir@procept-biorobotics.com. Learn More on Reza Zadno's contact information.

Has Reza Zadno been buying or selling shares of PROCEPT BioRobotics?

Reza Zadno has not been actively trading shares of PROCEPT BioRobotics in the last ninety days. Most recently, Reza Zadno sold 5,475 shares of the business's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $57.06, for a transaction totalling $312,403.50. Following the completion of the sale, the chief executive officer now directly owns 173,070 shares of the company's stock, valued at $9,875,374.20. Learn More on Reza Zadno's trading history.

Who are PROCEPT BioRobotics' active insiders?

PROCEPT BioRobotics' insider roster includes Antal Desai (Director), Frederic Moll (Director), Alaleh Nouri (EVP), Hisham Shiblaq (EVP, Chief Commercial Officer), Kevin Waters (EVP, CFO), and Reza Zadno (CEO). Learn More on PROCEPT BioRobotics' active insiders.

Are insiders buying or selling shares of PROCEPT BioRobotics?

In the last twelve months, insiders at the sold shares 20 times. They sold a total of 735,641 shares worth more than $62,839,018.02. The most recent insider tranaction occured on March, 18th when CEO Reza Zadno sold 5,475 shares worth more than $312,403.50. Insiders at PROCEPT BioRobotics own 17.4% of the company. Learn More about insider trades at PROCEPT BioRobotics.

Information on this page was last updated on 3/18/2025.

Reza Zadno Insider Trading History at PROCEPT BioRobotics

See Full Table

Reza Zadno Buying and Selling Activity at PROCEPT BioRobotics

This chart shows Reza Zadno's buying and selling at PROCEPT BioRobotics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20M$0$20MTotal Insider BuyingTotal Insider Selling

PROCEPT BioRobotics Company Overview

PROCEPT BioRobotics logo
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Read More

Today's Range

Now: $57.09
Low: $56.55
High: $58.79

50 Day Range

MA: $64.98
Low: $56.03
High: $74.69

2 Week Range

Now: $57.09
Low: $45.56
High: $103.81

Volume

654,615 shs

Average Volume

752,857 shs

Market Capitalization

$3.13 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.05